The 2010 State-of-the-Art Clinical Symposium offers attendees a chance to review the latest clinical and scientific information on topics such as the treatment and research of gout, rheumatoid arthritis, osteoarthritis, pediatrics, ultrasound, and cardiovascular comorbidities. The symposium—which provides a platform for attendees to have personal interactions with key opinion leaders in the field of rheumatology—will be held April 24–25 in Chicago, and will cover a range of diverse topics.
Search results for: cardiovascular disease
Drug Updates
Information on New Approvals and Medication Safety
Drug Updates
Information on New Approvals and Medication Safety
Coding Corner Answer
June’s Coding Answer
Vasculitis
A New perspective on when and how it begins
The Heart-SCC Puzzle
Identifying and treating cardiac involvement in systemic sclerosis can be a challenge
Drug Updates
Information on safety, labeling changes, and pharmaceutical research
Documentation History in Evaluation and Management Services
Does your staff know what is involved in taking a complete history from a patient?
Drug Updates
Information on safety, labeling changes, and pharmaceutical research
Systemic Lupus Erythematosus
Systemic lupus erythematosus, often called SLE or lupus, is a chronic inflammatory disease that can affect the skin, joints, kidneys, lungs, nervous system, and other organs of the body. It is sometimes labeled the “great imitator” because its wide variety of symptoms can often be confused with other disorders. Usually, patients with SLE experience skin rashes and arthritis as well as fatigue and fever, and the disease can be fatal. However, improvements in therapy have significantly increased these patients’ quality of life and their life expectancy.